55 research outputs found
The use of 1.5T magnetic resonance imaging for therapeutic decisions in patients with cardiac implantable electronic devices and significant neurological, neurosurgical and neuro-oncology diagnostic indications
Between September 2009 and May 2014 the classification of 36 patients with cardiac implantable electronic devices (CIEDs) in terms of the feasibility of MRI scanning due to strong clinical indications was carried out. Finally MRI examinations were performed in 20 patients, of whom 27 studies were conducted and a total number of 35 anatomical regions were scanned. Neurological, neurosurgical and neuro-oncology indications for MRI were reported in 19 patients (95%) in whom 26 MRI studies (96.3%) were performed, and 34 anatomical regions (97.1%) were scanned. One patient had indications for MRI in the field of cardiology.
Medical information obtained from 27 MRI studies allowed decisions to be made regarding the treatment in all patients. After 8 studies (29.6%), patients were classified into 9 different neurosurgical procedures. In the case of the remaining 19 studies (70.4%), there were no indications for surgical treatment and the decisions to implement conservative treatment were made.
There were no complications related to the implanted CIEDs observed: neither immediate nor in the follow-up.
Conclusions
(1)Magnetic resonance imaging studies in patients with non-MRI-conditional CIEDs in the vast majority are performed because of significant neurological, neurosurgical and neuro-oncology clinical indications.(2)Careful determination of the indications for MRI in each case allows the data necessary to be obtained to make definitive treatment decisions.(3)The adherence to examination protocol and device controlling procedures after MRI allows a very high safety profile of the method to be achieved
Electrocatalytic Oxygen Reduction in Alkaline Medium at Graphene-Supported Silver-Iron Carbon Nitride Sites Generated During Thermal Decomposition of Silver Hexacyanoferrate
n/
Ramipril z amlodipiną — nowy lek złożony w terapii hipotensyjnej
Złożone leki hipotensyjne zdobywają coraz większą popularność w terapii nadciśnienia tętniczego ze względu na dodatkowe korzyści, jakie przynoszą w zakresie wytrwałości terapeutycznej i poprawy współpracy pacjenta z lekarzem. W nadciśnieniu tętniczym II stopnia są podstawową opcją terapeutyczną. Ramipril z amlodipiną to nowe połączenia leków hipotensyjnych w preparacie złożonym dostępne na rynku farmaceutycznym w Polsce. W tym wypadku mamy do dyspozycji skojarzenie w jednej kapsułce wszechstronnie przebadanego inhibitora konwertazy angiotensyny z najpopularniejszym dihydropirydynowym antagonistą wapnia. Oba leki cechują korzystne wyniki dużych prób klinicznych z ich udziałem, zarówno w nadciśnieniu niepowikłanym, jak i w przypadku powikłań sercowo-naczyniowych.W badaniu oceniającym bezpośrednio preparat złożony ramipril–amlodipina wykazano jego wysoką skuteczność w obniżaniu ciśnienia tętniczego ocenianego metodą 24-godzinnego ABPM oraz w po miarach gabinetowych, a także ograniczenie występowania obrzęków kostek typowych dla amlodipiny. Leczenie było bardzo dobrze tolerowane przez 95% pacjentów.Naturalne wskazanie dla połączenia ramiprilu z amlodipiną to nadciśnienie tętnicze niepowikłane II stopnia niezależnie od ryzyka sercowo-naczyniowego, szczególnie pacjenci z towarzyszącym zespołem metabolicznym i/lub cukrzycą. W nadciśnieniu tętniczym powikłanym chorobą niedokrwienną serca, po przebytym incydencie wieńcowym połączenie ramiprilu z amlodipiną może być z powodzeniem stosowane łącznie z beta-adrenolitykiem, szczególnie w razie konieczności intensyfikacji leczenia hipotensyjnego lub przeciwdławicowego za pomocą 3 leków. Wydaje się, że połączenie ramiprilu z amlodipiną może być ciekawe z punktu widzenia chronoterapii w nadciśnieniu tętniczym z możliwością jego zastosowania w porze wieczornej u pacjentów typu nondipper
The effectiveness of transvenous leads extractions implanted more than 10 years before
Background: The increasing number of patients with cardiac implantable electronic devices (CIEDs) causes a rise in the absolute percentage of individuals qualifying for a transvenous lead extraction (TLE) due to infectious, vascular or lead failure related indications. As the survival time prolongs, TLE procedures more and more often concern the electrodes of long- -term functioning. Authors provide a retrospective analysis of the effectiveness and safety of TLE performed on leads implanted at least 10 years before the extraction. Methods: Between 2008 and 2012 we performed TLE of 364 electrodes in 217 patients. Out of these, 66 (18.1%) leads in 43 (19.8%) patients had been implanted for at least 10 years. The mean dwelling time for electrodes was 161 months (120 to 330). In 62% of cases CIED-related infection was an indication for TLE. The following extracting techniques were used: manual direct traction, device traction, mechanical telescopic sheaths, autorotational cutting sheaths and femoral approach. Results: Fifty-eight pacemakers and 8 defibrillating leads were extracted. Sixty-three (95%) completely, in the remaining 3 cases the clinical success was achieved with the small portion of the lead left into the vascular space. No major procedure complications were observed; minor complications were found in 3 (6%) patients. Conclusions: TLE with the use of various endovascular techniques is an effective and safe method for treating infectious, vascular and mechanical complications of long-lasting CIEDs therapy.
Doxorubicin–transferrin conjugate alters mitochondrial homeostasis and energy metabolism in human breast cancer cells
Doxorubicin (DOX) is considered one of the most powerful chemotherapeutic agents but its clinical use has several limitations, including cardiomyopathy and cellular resistance to the drug. By using transferrin (Tf) as a drug carrier, however, the adverse effects of doxorubicin as well as drug resistance can be reduced. The main objective of this study was to determine the exact nature and extent to which mitochondrial function is influenced by DOX–Tf conjugate treatment, specifically in human breast adenocarcinoma cells. We assessed the potential of DOX–Tf conjugate as a drug delivery system, monitoring its cytotoxicity using the MTT assay and ATP measurements. Moreover, we measured the alterations of mitochondrial function and oxidative stress markers. The effect of DOX–Tf was the most pronounced in MDA-MB-231, triple-negative breast cancer cells, whereas non-cancer endothelial HUVEC-ST cells were more resistant to DOX–Tf conjugate than to free DOX treatment. A different sensitivity of two investigate breast cancer cell lines corresponded to the functionality of their cellular antioxidant systems and expression of estrogen receptors. Our data also revealed that conjugate treatment mediated free radical generation and altered the mitochondrial bioenergetics in breast cancer cells.This work was supported in part by Grant No. B1511000001026.02 of the University of Lodz, Poland
Occurrence and extraction of implantable cardioverter-defibrillator leads with conductor externalization
Background: The increasing number of patients with implantable cardioverter-defibrillators (ICD) contributes to the rising number of patients qualifying for a transvenous lead extraction (TLE) due to infection, vascular or lead failure related indications. The purpose of this study was to perform a retrospective analysis of the occurrence of conductor externalization in TLE patients and to assess the success rate in the extraction of these leads. Methods: TLE procedure was performed between 2012 and 2014 of 428 electrodes in 259 patients. Out of these, 143 (33.4%) leads in 138 (52.9%) patients were ICD leads. The indications for the TLE in ICD patients were: infection in 37 patients, lead failure in 84 patients, and others in 17 patients. Conductor externalization was observed in 8 ICD leads (5.6%) in 8 (5.8%) patients. The mean dwelling time for externalized leads was 87.9 (55 to 132) months compared to 60.1 (3 to 246) months of the remaining 135 ICD leads (p = 0.0329). All externalized leads were successfully and completely extracted using device traction, mechanical telescopic sheaths and/or autorotational cutting sheaths. No complications of lead extraction procedures were observed in 8 patients with externalization. Results: Patients with lead externalization were often in a better New York Heart Association functional class (I or II) compared to those in the rest of the study group (p = 0.0212). Conclusions: Conductor externalization is a rare finding in patients undergoing TLE. This occurs with different manufacturers and lead types. In this complication transvenous lead extraction with the mechanical extraction tools can be safely performed.
Relationship between the gut microbiome and endometriosis and its role in pathogenesis, diagnosis, and treatment: a systematic review
Endometriosis is a chronic inflammatory disease affecting approximately 10% of women. It is defined as endometrial tissue outside of the uterus and produces a variety of symptoms including pelvic pain, dysmenorrhea, dyspareunia, and intermenstrual bleeding. Although several theories have been postulated regarding the pathogenesis of endometriosis, no theory has provided a complete explanation, therefore limiting our progress in diagnostic tools and management of endometriosis. Recently, much attention has been paid to the importance and role of the gut microbiome in endometriosis. As defined by Joshua Lederberg — microbiome is a set of the genome of microorganisms inhabiting a human body, including commensal, symbiotic and pathogenic microorganisms. The aim of this systematic review was to conduct a search in the Embase, Medline, and PubMed databases for literature from July 2013 to July 2023 regarding the relationship between the gut microbiome and endometriosis. 147 records were screened, of which 26 met the eligibility criteria, and 16 were included in this review. Our review concludes that patients with endometriosis show an altered gut microbiome, and that this has the potential to provide insight for pathogenesis, markers for diagnosis, as well as therapeutic options for treatment of endometriosis. Future research is necessary to confirm this and further investigate the relationship between the gut microbiome and endometriosis
Does exposure to nature make children more intelligent? : analysis in Polish children with and without ADHD
Previous studies have shown that exposure to nature and physical activity (PA) may be associated with higher intelligence in children. We examined whether there is an association between lifelong exposure to greenspace and bluespace and intelligence in children aged 10–13 with and without attention deficit hyperactivity disorder (ADHD), and whether PA mediates this association. The sample (N = 714) was collected within the NeuroSmog case-control study, where children with (N = 206) and without ADHD (N = 508) were recruited from 18 towns in Southern Poland. Nature exposure was estimated as the sum of the z-scores of the objective and perceived measures. Objective greenspace exposure was defined as the percentage of grass and tree cover in 500 m and 1 km buffers around lifelong residential addresses, respectively. Objective bluespace exposure was defined as the percentage of water cover in 500 m and 1 km buffers. Perceived greenspace/bluespace was measured as the parent-rated availability, quality, and use of greenspace/bluespace. Intelligence was assessed using the Polish version of the Stanford-Binet Intelligence Scales, 5th edition (SB5). SB5 Full Scale Intelligence Quotient (IQ), Nonverbal IQ, Verbal IQ, five factor and ten subtest scores were analysed as outcomes. The associations between nature and IQ scores were assessed by linear regressions separately for cases and controls, adjusting the models for sex, parental education, and urbanicity. Structural equation modeling was implemented to test whether PA mediated the association between nature and intelligence. None of the greenspace or bluespace measures were consistently associated with intelligence. PA was not found to be a mediator. We did not find evidence that higher lifelong nature exposure is associated with higher intelligence in Polish schoolchildren with or without ADHD. This casts doubts on whether exposure to nature has relevant influence on IQ
Effect of the 5-HTTLPR polymorphism on affective temperament, depression and body mass index in obesity
Background and aim: Many studies show high prevalence of affective disorders in obese patients.
Affective temperament is a subclinical manifestation of such conditions. The 5-HTT gene encoding the
serotonin transporter may be involved in both mood and eating dysregulation. The aim of this study was
to investigate the influence of a polymorphism in the 5-HTT gene on affective temperament types,
depressive symptoms and Body Mass Index (BMI) in obese patients.
Methods: This study involved 390 patients (237 females, and 153 males) with obesity. The TEMPS-A
questionnaire, Beck Depression Inventory (BDI) and Hamilton Depression Rating Scale (HDRS) were used
to evaluate affective temperaments and prevalence of depression. DNA was obtained for serotonin
transporter gene-linked polymorphism (5-HTTLPR) genotyping.
Results: In obese patients S/S genotype was associated with depressive and L/L with cyclothymic temperament.
Subjects with L/L genotype presented significantly higher BMI and greater intensity of
depressive symptoms in BDI and HDRS. Females scored higher in anxious and depressive, while males in
hyperthymic, cyclothymic and irritable temperaments. Females scored higher in BDI (subjective
depression) while males in HDRS (objective depression).
Limitations: TEMPS-A, BDI and HDRS are frequently used in studies on affective disorders. However,
these methods do not examine all dimensions of mood and personality.
Conclusions: In obese patients S allele of 5-HTTLPR was associated with development of depressive
temperament while L allele corresponded with greater obesity and prevalence of depression. Different
mechanisms may be involved in manifestation of depression in males and females with obesity
- …